MR Spectroscopy of the Cervical Spinal Cord in Chronic Spinal Cord Injury.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 30 1 2019
medline: 24 12 2019
entrez: 30 1 2019
Statut: ppublish

Résumé

Purpose To investigate metabolic changes in chronic spinal cord injury (SCI) by applying MR spectroscopy in the cervical spinal cord. Materials and Methods Single-voxel short-echo spectroscopic data in study participants with chronic SCI and healthy control subjects were prospectively acquired in the cervical spinal cord at C2 above the level of injury between March 2016 and January 2017 and were compared between groups. Concentrations of total N-acetylaspartate (tNAA), myo-inositol (mI), total choline-containing compounds (tCho), creatine, and glutamine and glutamate complex were estimated from the acquired spectra. Participants were assessed with a comprehensive clinical evaluation investigating sensory and motor deficits. Correlation analysis was applied to investigate relationships between observed metabolic differences, lesion severity, and clinical outcome. Results There were 18 male study participants with chronic SCI (median age, 51 years; range, 30-68 years) and 11 male healthy control subjects (median age, 45 years; range, 30-67 years). At cervical level C2, tNAA/mI and tCho/mI ratios were lower in participants with SCI (tNAA/mI: -26%, P = .003; tCho/mI: -18%; P = .04) than in healthy control subjects. The magnitude of difference was greater with the severity of cord atrophy (tNAA/mI: R

Identifiants

pubmed: 30694162
doi: 10.1148/radiol.2018181037
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-138

Commentaires et corrections

Type : CommentIn

Auteurs

Patrik O Wyss (PO)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Eveline Huber (E)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Armin Curt (A)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Spyros Kollias (S)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Patrick Freund (P)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Anke Henning (A)

From the Institute for Biomedical Engineering, University and ETH Zurich, Gloriastrasse 35, CH-8092 Zurich, Switzerland (P.O.W., A.H.); Department of Radiology, Swiss Paraplegic Centre, Nottwil, Switzerland (P.O.W.); Max Planck Institute for Biological Cybernetics, Tuebingen, Germany (P.O.W., A.H.); Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland (E.H., A.C., P.F.); Institute of Neuroradiology, University Hospital, Zurich, Switzerland (S.K.); Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, University College London, England (P.F.); Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, England (P.F.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Institute of Physics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany (A.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH